Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Eight-hour early versus late eating windows to improve blood sugar and cardiometabolic health in overweight adults

Official title: Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes: the GLYCOTIME Trial

Run by German Institute of Human Nutrition · NCT07171281 · Data updated 2026-11-12

We will try early versus late 8-hour time-restricted eating with moderate calorie reduction to see if it improves blood sugar and heart-related health in adults who are overweight with normal glucose, prediabetes, or non-insulin-treated type 2 diabetes.

More Type 2 Diabetes trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorGerman Institute of Human Nutrition
Academic / other
Locations1 site (Nuthetal)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedDecember 31, 2027
Study endsFebruary 28, 2028
Registry record updatedSeptember 29, 2026
Trial IDNCT07171281 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with BMI 25–40 kg/m² who currently eat across at least 12 hours per day and have normal glucose, prediabetes, or non-insulin-treated type 2 diabetes, and who can attend on-site visits.

Probably not a fit

People on insulin, recent major illness or cardiovascular events, shift workers, pregnant or breastfeeding people, those already practicing time-restricted eating, or those with incompatible medical conditions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a crossover dietary intervention where participants follow two 5-week hypocaloric, 8-hour eating-window diets: one window predominantly in the morning (early TRE) and one predominantly in the afternoon (late TRE). A 10–12 week washout separates the intervention periods to reduce carryover effects. The study measures glucose metabolism and a range of cardiometabolic parameters, and collects biological samples to explore molecular mechanisms. Participants include adults with BMI 25–40 kg/m² who have normal glucose, prediabetes, or type 2 diabetes not treated with insulin.

Why it matters

Potential benefit: If successful, it could offer a low-cost, medication-free way to improve blood sugar control and reduce cardiometabolic risk by changing when people eat.

How similar studies have gone: Previous time-restricted eating trials have shown weight loss and improvements in some metabolic markers, but direct comparisons of early versus late windows and detailed molecular mechanism data are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Overweight or obesity (BMI 25-40 kg/m²)
* Healthy glucose metabolism (fasting glucose \<100 mg/dl and glucose after 2 hours OGTT \<140 mg/dl)
* OR impaired glucose metabolism (fasting glucose 100-125 mg/dl and/or glucose after 2 hours OGTT 140-199 mg/dl and/or HbA1c 5.7-6.4%)
* OR type 2 diabetes (according to existing medical diagnosis or fasting glucose \>126 mg/dl and/or glucose after 2 hours OGTT \>200 mg/dl and/or HbA1c ≥6.5%)
* Daily eating window ≥12 hours

Exclusion Criteria:

* Weight changes \> 5% within past 3 months
* Shift work
* Traveling across more than one time zone within one month prior to the study
* Pregnancy and breastfeeding
* Eating disorders, food intolerance/allergy to ingredients in the diet product, vegan diet, practicing time-restricted eating
* Severe chronic illnesses or other conditions that are incompatible with the planned intervention and examination program (e.g. type 1 diabetes, recent cardiovascular event, malabsorption, cancer in the last two years, etc.)
* Treatment with insulin, sulfonylureas, and GLP-1 receptor agonists, steroid use (oral, cutaneous, or parenteral), regular intake of melatonin, anticoagulation treatment that cannot be paused
* Extreme early and extreme late chronotypes

Where it's running

  • German Institute of Human Nutrition Potsdam-Rehbruecke
    Nuthetal, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.